In a pediatric emergency room, the question is often simple: is this a viral sore throat, or a bacterial strep infection that needs antibiotics? The answer can mean hours in a waiting room, a rapid test, and a prescription that may or may not be necessary. CurieDx, a Baltimore startup spun out of Johns Hopkins, is betting that a smartphone camera and a clinically trained algorithm can answer that question from a patient’s home, turning a common point of care into a remote diagnostic tool [Johns Hopkins Technology Ventures].
The company’s iOS app, available on the Apple App Store, asks users to take a photo of their throat. Its AI model, developed on datasets from the Johns Hopkins School of Medicine, analyzes the image and provides a risk assessment for strep throat [curiedx.com/strep-app, 2026]. The goal is not to replace a doctor’s diagnosis, but to provide a faster, data-informed triage tool that can guide patients and clinicians, especially in telehealth settings where physical exams are impossible [Johns Hopkins Technology Ventures].
A Clinical Wedge for Consumer Phones
CurieDx’s founding team gives its product a credibility that many consumer health apps lack. CEO Therese Canares is a practicing pediatric emergency medicine physician at Johns Hopkins, while technical co-founder Mathias Unberath is a computer science professor specializing in medical imaging and AI [Johns Hopkins Technology Ventures]. Their collaboration grounds the product in real clinical workflow needs, not just technical possibility. The initial focus on strep throat is a deliberate wedge; it’s a high-volume, visually diagnosable condition where timely treatment matters and over-prescription of antibiotics is a public health concern.
The company is pursuing a dual-track strategy. The app is available directly to consumers, but the larger bet appears to be on clinicians and telehealth providers integrating CurieDx into their remote care protocols. For a virtual urgent care service, the tool could help decide which patients need to come in for a confirmatory test and which can be managed at home, potentially reducing unnecessary visits [Johns Hopkins Technology Ventures]. The platform is also designed to analyze images of other point-of-care tests, like urine dipsticks for UTIs, suggesting a path beyond otolaryngology [Johns Hopkins Technology Ventures].
The Regulatory and Competitive Landscape
Operating at the intersection of software and diagnosis means navigating a complex regulatory environment. CurieDx positions its tool as providing “risk assessments” and guidance, which may allow it to avoid the more stringent FDA clearance pathway required for definitive diagnostic devices, at least initially. This is a common, careful approach for digital health tools aiming for speed to market. The company’s academic backing and early support from the National Science Foundation are positive signals for its technical rigor [National Science Foundation].
CurieDx is not alone in trying to turn smartphones into diagnostic tools. Its space includes competitors like Healthy.io, which uses smartphone cameras to analyze urine test strips, and Scanwell, which focused on at-home tests. The competitive differentiation for CurieDx rests on two pillars: its deep clinical co-founding and its focus on acute, high-urgency infections where a faster answer has immediate value.
| Company | Primary Focus | Key Differentiator |
|---|---|---|
| CurieDx | Strep throat, UTI risk from photos | Clinical co-founding (Johns Hopkins ER physician + AI professor) |
| Healthy.io | Urinalysis, chronic condition monitoring (e.g., albumin) | FDA-cleared tests, partnerships with health systems |
| Scanwell (acquired by BD) | At-home UTI, fertility tests | Consumer brand, acquisition by large medtech player |
The Road from Pilot to Practice
The company’s public traction appears early-stage. While the app is live, there are no disclosed large-scale enterprise contracts or major funding rounds beyond its foundational grants. The path from a promising academic project to a scaled clinical tool involves significant hurdles. These include proving the algorithm’s performance across diverse populations in real-world settings, securing reimbursement pathways, and building the sales motion to integrate into health system IT stacks.
For now, the bet is on the clinical need and the team’s ability to address it. The potential impact is clearest in the condition it first targets. For a parent with a sick child at 10 p.m., the standard of care today often involves a stressful trip to an urgent care center, a long wait, and a rapid strep test. A reliable, guided self-assessment could provide reassurance or a clear signal to seek care, streamlining a fragmented process. CurieDx is attempting to build that bridge, one smartphone photo at a time.
Sources
- [Johns Hopkins Technology Ventures] 10 Innovations in 10 Years: CurieDx | https://ventures.jhu.edu/news/10-innovations-in-10-years-curiedx/
- [curiedx.com/strep-app, 2026] App to screen for strep throat: StrepAI | https://www.curiedx.com/strep-app
- [National Science Foundation] Support noted in company profile |
- [Apple App Store] CurieDx app listing | https://apps.apple.com/us/app/curiedx/id6496601748
- [LinkedIn] CurieDx company page | https://www.linkedin.com/company/curiedx